Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Benzodiazepines for Alcohol Withdrawal

About this resource:

Systematic Review

Source: The Cochrane Collaborative

Last Reviewed: March 2010

Workgroups: Substance Use Workgroup

In this Cochrane systematic review, the Cochrane Collaborative found that benzodiazepines are more effective than placebo for protecting against seizures caused by alcohol withdrawal syndrome. Researchers also found that benzodiazepines may offer protection against many outcomes when compared with other medicines. They noted that they couldn’t draw definite conclusions about safety and effectiveness because of differences across trial interventions and outcomes.

Read more about this resource

Objectives related to this resource (1)

Reduce the proportion of people who had alcohol use disorder in the past year — SU‑13
Little or no detectable change

Suggested Citation

1.

Amato, L., Minozzi, S., Vecchi, S. & Davoli, M. (2010). Benzodiazepines for alcohol withdrawal. Cochrane Database of Systematic Reviews, 2010 (3). DOI: 10.1002/14651858.CD005063.pub3.